GGrantIndex
← Leaderboards

Marc Ferrer-Alegre

National Center For Advancing Translational Sciences

Google Scholar ↗PubMed ↗ORCID ↗
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

—

By mechanism

—

Top collaborators

No co-investigators on record.

Most similar at National Center For Advancing Translational Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Screening”

Research focus

ScreeningDrug DiscoveryCollaborationsPharmaceutical PreparationsHigh Throughput ScreeningUnited States National Institutes Of HealthNovel TherapeuticsTherapeutic DevelopmentBaseDrug DevelopmentPhenotypeResearch PersonnelValidationResourcesSmall MoleculeExtramural ActivitiesCommunitiesPharmaceutical ChemistryInformaticsAssay DevelopmentNew TechnologyBiologyGenomicsHuman Disease

Grant awards (56)

COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses$1,594,895
ZIA · FY2021 · TR · contact PI
3D Bioprinted lung cancer models for drug screening$737,751
ZIA · FY2021 · TR · contact PI
3D Bioprinted Omentum tissue to model ovarian cancer metastasis$737,751
ZIA · FY2021 · TR · contact PI
3D Bioprinted skin models for drug screening$737,751
ZIA · FY2021 · TR · contact PI
3D Bioprinted retina models for drug screening$737,750
ZIA · FY2021 · TR · contact PI
Helping to End Addiction Long-term (HEAL): 3D Bioprinted Tissue Models$417,197
ZIA · FY2021 · TR · contact PI
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses$62,221
ZIA · FY2021 · TR · contact PI
HEAL: 3D Bioprinted Tissue Models$1,287,813
ZIA · FY2020 · TR · contact PI
3D Bioprinted Omentum tissue to model ovarian cancer metastasis$725,728
ZIA · FY2020 · TR · contact PI
3D Bioprinted skin models for drug screening$725,728
ZIA · FY2020 · TR · contact PI
3D Bioprinted retina models for drug screening$725,727
ZIA · FY2020 · TR · contact PI
3D Bioprinted lung cancer models for drug screening$725,727
ZIA · FY2020 · TR · contact PI
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses$711,776
ZIA · FY2020 · TR · contact PI
HEAL: 3D Bioprinted Tissue Models$3,813,602
ZIA · FY2019 · TR · contact PI
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery$2,644,877
ZIA · FY2019 · TR · contact PI
Identification of small molecule inhibitors of miR-155 expression in Th17 cells$132,650
ZIA · FY2019 · TR · contact PI
High Content Screening using 3-D Models of Ovarian Cancer$47,590
ZIA · FY2019 · TR · contact PI
HEAL: 3D Bioprinted Tissue Models$3,461,610
ZIA · FY2018 · TR · contact PI
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery$1,840,012
ZIA · FY2018 · TR · contact PI
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$245,080
ZIA · FY2018 · TR · contact PI
High-throughput screening to identify IP6K1 inhibitors as novel therapeutics for psychiatric disorders$245,080
ZIA · FY2018 · TR · contact PI
SABRE: a modified gene trap approach for cancer drug discovery$245,080
ZIA · FY2018 · TR · contact PI
Development of a novel pharmacologic strategy to activate normal pathways of differentiation in melanoma$245,080
ZIA · FY2018 · TR · contact PI
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$245,080
ZIA · FY2018 · TR · contact PI
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes$127,680
ZIA · FY2018 · TR · contact PI
Identification of small molecule inhibitors of miR-155 expression in Th17 cells$127,680
ZIA · FY2018 · TR · contact PI
Identification small molecules that regulate T helper cell differentiation$127,680
ZIA · FY2018 · TR · contact PI
Identification of GPR32 agonists as potential anti-inflammatory agents$127,680
ZIA · FY2018 · TR · contact PI
Identification of compounds that inhibit the interaction between IQGAP1 and Cdc42 and Rac1 for the treatment of cancer$127,680
ZIA · FY2018 · TR · contact PI
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma$127,680
ZIA · FY2018 · TR · contact PI
Identification of small molecules that increase activity of the huntingtin antisense promoter for the potential treatment of Huntington Disease$127,680
ZIA · FY2018 · TR · contact PI
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease$127,680
ZIA · FY2018 · TR · contact PI
Identification and characterization of novel senolytic agents$40,790
ZIA · FY2018 · TR · contact PI
High Content Screening using 3-D Models of Ovarian Cancer$40,790
ZIA · FY2018 · TR · contact PI
Identification of modulators of TRAP1$37,463
ZIA · FY2018 · TR · contact PI
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery$1,618,900
ZIA · FY2017 · TR · contact PI
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening$180,000
ZIA · FY2017 · TR · contact PI
Identification of formin-2 (FMN2) modulators as anti-metastatic agents$44,666
ZIA · FY2017 · TR · contact PI
Identification and characterization of novel senolytic agents$44,666
ZIA · FY2017 · TR · contact PI
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease$44,666
ZIA · FY2017 · TR · contact PI
Identification of small molecules that increase activity of the huntingtin antisense promoter for the potential treatment of Huntington Disease$44,666
ZIA · FY2017 · TR · contact PI
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma$44,666
ZIA · FY2017 · TR · contact PI
Fission Yeast as an HTS Platform to Identify New Probes with HIV-1 Vpr-mediated Antiviral Activity$44,666
ZIA · FY2017 · TR · contact PI
Development of a novel pharmacologic strategy to activate normal pathways of differentiation in melanoma$44,666
ZIA · FY2017 · TR · contact PI
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$44,666
ZIA · FY2017 · TR · contact PI
Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening$44,666
ZIA · FY2017 · TR · contact PI
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$44,666
ZIA · FY2017 · TR · contact PI
Identification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders$44,666
ZIA · FY2017 · TR · contact PI
Identification of compounds that inhibit the interaction between IQGAP1 and Cdc42 and Rac1 for the treatment of cancer$44,666
ZIA · FY2017 · TR · contact PI
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$44,666
ZIA · FY2017 · TR · contact PI
Identification of small molecule inhibitors of miR-155 expression in Th17 cells$44,666
ZIA · FY2017 · TR · contact PI
Identification of GPR32 agonists as potential anti-inflammatory agents$44,666
ZIA · FY2017 · TR · contact PI
High Content Screening using 3-D Models of Ovarian Cancer$44,666
ZIA · FY2017 · TR · contact PI
Identification of modulators of slow growth gene regulation for antifungal and anticancer applications$44,666
ZIA · FY2017 · TR · contact PI
Identification of modulators of TRAP1$44,666
ZIA · FY2017 · TR · contact PI
Identification of NOD1/2 activators as potential antivirals$44,666
ZIA · FY2017 · TR · contact PI